Envision Pharma Group – Our new office in Wilmslow, Cheshire is now open and operations will be led by Anne Clare Wadsworth

PR icon

PRESS RELEASE

Apr 26, 2016

Envision Pharma Group – Our new office in Wilmslow, Cheshire is now open and operations will be led by Anne Clare Wadsworth

Horsham, UK, 26 April, 2016 – Envision Pharma Group (“Envision”), a highly successful Medical Affairs-focused, technology-enabled scientific communications company is delighted to announce that Anne Clare Wadsworth has joined the Envision management team. Anne Clare will lead our newly opened office in Wilmslow, Cheshire and brings a wealth of experience in healthcare communications and in building and directing multi-channel medical communication programs across international markets. Her strong agency leadership and team-building capabilities will continue Envision’s service excellence at all stages of interaction with both clients and healthcare professionals.

 

Anne Clare joins the Envision management team that oversees operations in Wilmslow, and across our nine other offices in the UK, US, and Asia-Pacific. As part of our continued expansion, Wilmslow, will serve as a North West office for the expansion of Envision’s core services and will also act as a head office for the Alligent Group’s (“Alligent”) European operations. Alligent, a leading Medical Affairs agency that develops and delivers strategically focused, integrated and aligned medical communications solutions to the biopharma industry, became part of the Envision Pharma Group in September, 2015. 

 

Envision’s CEO, Brian Hepburn, commented, “The new office in Wilmslow not only provides a base for Alligent’s European operations, but continues Envision’s structured expansion with an office in the North West of England, a traditional centre of excellence for medical communications. The new location, coupled with Anne Clare’s leadership capabilities and client-centric approach, will help drive the continued expansion of Envision’s service line capabilities while establishing Alligent’s European operations as this business unit continues to thrive.”

 

Alligent Group founders, David Thompson and Joe Kohles, added, “We are delighted to open our Wilmslow office with such a well-recognized and vastly experienced medical communications leader in Anne Clare. Under her stewardship we are confident Envision’s North West footprint will grow rapidly as a centre of excellence for the industry’s brightest talent as well as serve as a commercial hub for Alligent's thriving European medical strategy business.”  

 

The Envision Pharma Group, including the Alligent European team, are still recruiting for open positions at the level of Scientific Director, Medical Writer (all levels), Account Manager and Account Director.

For an informal discussion, or to apply for any of these roles, please contact Karen Kent (Envision Pharma Group Recruiter – Karen.Kent@EnvisionPharmaGroup.com) or Anne Clare Wadsworth (Head of Alligent Europe − Anne-Clare.Wadsworth@EnvisionPharmaGroup.com).

 

About Envision

Founded in 2001, Envision Pharma Group is an international, innovative, global technology and scientific communication company serving the medical affairs requirements of pharmaceutical, biotechnology, and medical device companies. Initially focusing on publication planning, Envision has evolved to become a leading provider of evidence-based communication services, encompassing all aspects of scientifically driven data dissemination activities required to support a successful “access to market strategy” for new biopharma products.

 

This capability of the organization is further enhanced with industry-leading, complementary technology solutions. Envision has grown steadily under consistent leadership across its three core business areas in support of the Medical Affairs Team that include (i) Evidence Communication – including strategic publication planning, data dissemination services, Med Ed and market access communications; (ii) Technology Solutions – design, development, implementation, and support of innovative and strategic management software purpose-built for life-science clients including publication planning and management (Datavision®), clearance approval (Clear®), activity request management (Visiontracker®), workflow management for HEOR activities (Visiontracker HEORTM), searchable repository for the sharing of appropriate educational and training materials (LibraryTM), and next generation solution for managing medical enquiries (MedinfoTM); (iii) Consulting Solutions – policy, process, compliance, and guideline consultancy to life-science companies.

 

Envision currently has ten offices, three in the United Kingdom – Horsham, Wilmslow and London; five in the United States – Philadelphia, PA, Southport, CT, Madison, NJ, Stirling, NJ,  Glastonbury, CT; and two in Asia-Pacific – Tokyo and Sydney. The company employs approximately 460 team members, including over 185 highly qualified and experienced in-house medical writers and a more than 70-strong technology solutions team providing platform development and customer support. Envision currently provides service and product solutions to more than 75 client companies, including 18 of the top 20 pharmaceutical companies.

 

About the Alligent Group

Alligent was acquired by the Envision Pharma Group in September, 2015. Alligent was built to support the strategic and tactical needs of our clients’ medical directors and currently provides strategic medical planning and program implementation for the Medical Affairs Departments of a number of leading biopharma organizations. Based in Stirling, NJ, the company employs over 50 communications and scientific experts with extensive industry and agency experience, particularly within the area of oncology. 

 

Envision Pharma Group logo